Synapse

← Jürgen C. Becker

Papers by Jürgen C. Becker

Page 6 · newest first

  1. In vivo effects of an Er:YAG Laser, an ultrasonic system and scaling and root planing on the biocompatibility of periodontally diseased root surfaces in cultures of human PDL fibroblastsLasers in Surgery and Medicine · 2003
  2. Prospective Randomized Trial of Interferon Alfa-2b and Interleukin-2 as Adjuvant Treatment for Resected Intermediate- and High-Risk Primary Melanoma Without Clinically Detectable Node MetastasisJournal of Clinical Oncology · 2003
  3. Periodontal Treatment with an Er:YAG Laser or Scaling and Root Planing. A 2‐Year Follow‐Up Split‐Mouth StudyJournal of Periodontology · 2003
  4. Specific peptide-mediated immunity against established melanoma tumors with dendritic cells requires IL-2 and fetal calf serum-free cell cultureEuropean Journal of Immunology · 2002
  5. Classical chemotherapy for metastatic melanomaClinical and Experimental Dermatology · 2000
  6. Sequential interferon-α2b, interleukin-2 and fotemustine for patients with metastatic melanomaMelanoma Research · 2000
  7. Expression and activation of matrix metalloproteinase‐2 (MMP‐2) and its co‐localization with membrane‐type 1 matrix metalloproteinase (MT1‐MMP) correlate with melanoma progressionThe Journal of Pathology · 2000
  8. CD40-Ligated Dendritic Cells Effectively Expand Melanoma-Specific CD8+ CTLs and CD4+ IFN-γ-Producing T Cells from Tumor-Infiltrating LymphocytesThe Journal of Immunology · 2000
  9. In Situ T Cell Responses Against Melanoma Comprise High Numbers of Locally Expanded T Cell ClonotypesThe Journal of Immunology · 1999
  10. Activation of preexisting T cell clones by targeted interleukin 2 therapyProceedings of the National Academy of Sciences · 1998
  11. p53 gene mutations and HPV infection in primary head and neck squamous cell carcinomas do not correlate with overall survival: a long term follow‐up studyJournal of Oral Pathology and Medicine · 1997
  12. Long-lived and transferable tumor immunity in mice after targeted interleukin-2 therapy.Journal of Clinical Investigation · 1996
  13. An antibody-interleukin 2 fusion protein overcomes tumor heterogeneity by induction of a cellular immune response.Proceedings of the National Academy of Sciences · 1996
  14. Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis.Journal of Clinical Investigation · 1996
  15. Clonal T cell responses in tumor infiltrating lymphocytes from both regressive and progressive regions of primary human malignant melanoma.Journal of Clinical Investigation · 1996
  16. T cell-mediated eradication of murine metastatic melanoma induced by targeted interleukin 2 therapy.The Journal of Experimental Medicine · 1996
  17. Eradication of human hepatic and pulmonary melanoma metastases in SCID mice by antibody-interleukin 2 fusion proteins.Proceedings of the National Academy of Sciences · 1996
  18. Human neural cell adhesion molecule L1 and rat homologue NILE are ligands for integrin alpha v beta 3.The Journal of Cell Biology · 1996
  19. 11 A prospective randomized multi-centre trial for the treatment of primary high-risk melanoma using s.c. interleukin-2 and interferon ??Melanoma Research · 1995
  20. DNA loops induced by cooperative binding of transcriptional activator proteins and preinitiation complexes.Proceedings of the National Academy of Sciences · 1995
  21. Induction of carcinoma cell migration on vitronectin by NF-kappa B-dependent gene expression.Molecular Biology of the Cell · 1995
  22. Altered expression of extracellular matrix proteins and integrins in oral lichen planus (OLP)Journal of Oral Pathology and Medicine · 1995
  23. Negative transcriptional regulation in anergic T cells.Proceedings of the National Academy of Sciences · 1995
  24. A multicenter phase II clinical trial using dacarbazine and continuous infusion lnterleukin-2 for metastatic melanoma. Clinical data and immunomonitoringCancer · 1995
  25. Prevention of anergy induction in cloned T cells by interleukin 12Experimental Dermatology · 1994
  26. Distribution of procollagen type III, collagen type VI and tenascin in oral submucous fibrosis (OSF)Journal of Oral Pathology and Medicine · 1994
  27. Antiphospholipid syndrome associated with immunotherapy for patients with melanomaCancer · 1994
  28. Maintenance of clonal anergy by endogenously produced IL-10International Immunology · 1994
  29. Soluble intercellular adhesion molecule-1 inhibits MHC-restricted specific T cell/tumor interaction.The Journal of Immunology · 1993
  30. Immunohistochemical distribution of collagens type I, III, IV and VI, of undulin and of tenascin in oral fibrous hyperplasiaJournal of Oral Pathology and Medicine · 1993
  31. T cells migrate to tumour sites after extracorporeal interleukin 2 stimulation and reinfusion in a patient with metastatic melanomaBritish Journal of Dermatology · 1993
  32. Comparative Studies on the Detection of Benzodiazepines in Serum by Means of Immunoassays (FPIA)Journal of Analytical Toxicology · 1993
  33. Distribution of undulin, tenascin, and fibronectin in the human periodontal ligament and cementum: comparative immunoelectron microscopy with ultra-thin cryosections.Journal of Histochemistry & Cytochemistry · 1993
  34. Tumor escape mechanisms from immunosurveillance: induction of unresponsiveness in a specific MHC-restricted CD4⁺; human T cell clone by the autologous MHC class II⁺ melanomaInternational Immunology · 1993
  35. Tumour-infiltrating lymphocytes in primary melanoma: functional consequences of differential IL-2 receptor expressionClinical & Experimental Immunology · 1993
  36. Circulating Intercellular Adhesion Molecule-1 in Melanoma Patients: Induction by Interleukin-2 TherapyJournal of Immunotherapy · 1992
  37. Non‐MHC‐Restricted T‐Cell Interaction with B Cells: Role of the T‐Cell ReceptorScandinavian Journal of Immunology · 1992
  38. Ectomesenchyme of ameloblastic fibroma reveals a characteristic distribution of extracellular matrix proteinsJournal of Oral Pathology and Medicine · 1992
  39. Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicityThe Journal of Immunology · 1991
  40. Expression of proteins encoded by Epstein-Barr virus trans-activator genes depends on the differentiation of epithelial cells in oral hairy leukoplakia.Proceedings of the National Academy of Sciences · 1991
  41. Distribution of collagens type V and VI in the normal human alveolar mucosa: An immunoelectronmicroscopic study using ultrathin frozen sectionsJournal of Periodontal Research · 1991
  42. Comparative investigation of c-erbB2/neu expression in head and neck tumors and mammary cancerCancer · 1991
  43. Immunoelectron microscopic localization of collagens type I, V, VI and of procollagen type III in human periodontal ligament and cementum.Journal of Histochemistry & Cytochemistry · 1991
  44. Human Natural Killer Clones Enhance in Vitro Antibody Production by Tumour Necrosis Factor Alpha and Gamma InterferonScandinavian Journal of Immunology · 1990
  45. Undulin, an extracellular matrix glycoprotein associated with collagen fibrils.Journal of Biological Chemistry · 1990
  46. Oral hairy leukoplakia: observations in 95 cases and review of the literatureJournal of Oral Pathology and Medicine · 1989
  47. Immunohistochemical distribution of collagens types IV, V, and VI and of pro-collagens types I and III in human alveolar bone and dentine.Journal of Histochemistry & Cytochemistry · 1986
  48. Oral lichen planus: characterization of immunocompetent cells with hybridoma antibodiesJournal of Oral Pathology and Medicine · 1983